Home / NYMXF : OTC

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does NYMXF make money? Does NYMXF have pricing power? What's the Earnings Whisper? Will NYMXF profit more as the business scales? What is NYMXF's management track record? Is NYMXF's current price justified?

Nymox Pharmaceutical Corporation

$0 -$0.05 (-99.57%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.01

Year Range

$0$0.2

Market Cap

18.91K

AVG Volume

31.63K

Trailing/Forward PE

-0/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Net Income (USD)

NYMXF Net Income (USD) by quarter
Period	Net Income (USD)
24 Q4	-857K
24 Q3	-716K
23 Q4	-5.31M
23 Q3	-1.04M
23 Q2	-1.11M
23 Q1	-1.39M
22 Q4	-1.34M
22 Q3	-1.49M
22 Q2	1.34M
22 Q1	-5.09M

Operating Income (USD)

NYMXF Operating Income (USD) by quarter
Period	Operating Income (USD)
24 Q4	-788K
24 Q3	-653K
23 Q4	-4.85M
23 Q3	-1.01M
23 Q2	-1.1M
23 Q1	-1.39M
22 Q4	1.67M
22 Q3	-1.48M
22 Q2	-1.77M
22 Q1	-5.07M

EBITDA (USD)

NYMXF EBITDA (USD) by quarter
Period	EBITDA (USD)
24 Q4	-771K
24 Q3	-653K
23 Q4	-5.27M
23 Q3	-1.01M
23 Q2	-1.1M
23 Q1	-1.38M
22 Q4	-1.32M
22 Q3	-1.48M
22 Q2	-1.77M
22 Q1	-5.07M

Cash Flows (USD)

NYMXF Cash Flows (USD) by quarter
Period	Cash Flows (USD)
24 Q4	-717K
23 Q4	-897K
23 Q3	-1.27M
23 Q2	-915.72K
23 Q1	-991K
22 Q4	-1.11M
22 Q3	-1.25M
22 Q2	1.57M
22 Q1	-4.21M
21 Q4	-2.23M

EPS (USD)

NYMXF EPS (USD) by quarter
Period	EPS (USD)
24 Q4	-0.01
24 Q3	-0.01
23 Q4	-0.06
23 Q3	-0.01
23 Q2	-0.01
23 Q1	-0.02
22 Q4	-0.01
22 Q3	-0.02
22 Q2	0.01
22 Q1	-0.06

Expenses (USD)

NYMXF Expenses (USD) by quarter
Period	Expenses (USD)
21 Q4	3.98K
24 Q4	788K
24 Q3	653K
23 Q4	4.85M
23 Q3	1.01M
23 Q2	1.1M
23 Q1	1.39M
22 Q4	-3.94M
22 Q3	1.48M
22 Q2	1.77M
22 Q1	5.07M

Cash & Debt (USD)

NYMXF Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
24 Q4	74K
24 Q3	41K
23 Q4	70K
23 Q3	76K
23 Q2	132K
23 Q1	351K
22 Q4	1.4M
22 Q3	2.7M
22 Q2	4.07M
22 Q1	672K

Debt ratios

NYMXF Debt ratios by quarter
Period	Debt ratios
24 Q4	0.01
24 Q3	-0.32
23 Q4	-0.08
23 Q3	0.01
23 Q2	-0.13
23 Q1	0.04
22 Q4	0.13
22 Q3	0.22
22 Q2	0.29

Return on Capital

NYMXF Return on Capital by quarter
Period	Return on Capital
24 Q4	12.65%
24 Q3	11.37%
23 Q4	167.38%
23 Q3	54.47%
23 Q2	38.58%
23 Q1	77.1%
22 Q4	277.8%
22 Q3	-109.47%
22 Q2	47.5%
22 Q1	-462.78%

Shares Outstanding

NYMXF Shares Outstanding by quarter
Period	Shares Outstanding
24 Q4	94.23M
24 Q3	93.54M
23 Q4	93.54M
23 Q3	92.16M
23 Q2	91.27M
23 Q1	90.52M
22 Q4	90.52M
22 Q3	91.27M
22 Q2	90.42M
22 Q1	86.03M

Book Value Per Share (USD)

NYMXF Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
24 Q4	-0.07
24 Q3	-0.07
23 Q4	-0.03
23 Q3	-0.02
23 Q2	-0.03
23 Q1	-0.02
22 Q4	-0.01
22 Q3	0.01
22 Q2	0.03
22 Q1	0.01

Total Assets (USD)

NYMXF Total Assets (USD) by quarter
Period	Total Assets (USD)
24 Q4	654K
24 Q3	624K
23 Q4	627K
23 Q3	669K
23 Q2	271K
23 Q1	575K
22 Q4	1.62M
22 Q3	3.73M
22 Q2	5.06M
22 Q1	3.73M

Employee Count

NYMXF Employee Count by quarter
Period	Employee Count
2022	33
2021	3
2020	3
2019	3
2018	5
2017	2
2016	4
2015	4
2014	8
2013	24

Free Cash Flow Yield

NYMXF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Dec 24	-39.41%
Dec 24	-31.1%
Dec 24	-54.43%
Dec 24	-31.1%
Nov 24	-57.98%
Nov 24	-83.74%
Nov 24	-83.74%
Nov 24	-87.09%
Nov 24	-29.03%
Oct 24	-27.22%
Oct 24	-29.03%
Oct 24	-29.03%
Oct 24	-33.5%
Sep 24	-36.29%
Sep 24	-39.59%
Sep 24	-29.03%
Sep 24	-17.08%
Aug 24	-6220.87%
Aug 24	-14515.36%
Aug 24	-169.44%
Aug 24	-14515.36%
Aug 24	-14515.36%
Jul 24	-12.81%
Jul 24	-27.05%
Jul 24	-23.47%
Jul 24	-21.77%
Jun 24	-22.92%
Jun 24	-18.94%
Jun 24	-48.38%
Jun 24	-22.92%
May 24	-16.75%
May 24	-18.15%
May 24	-20.07%
May 24	-16.94%
May 24	-16.13%
Apr 24	-14.52%
Apr 24	-15.01%
Apr 24	-12.1%
Apr 24	-12.44%
Mar 24	-11.62%
Mar 24	-11.62%
Mar 24	-11.33%
Mar 24	-11.13%
Mar 24	-13.24%
Feb 24	-10.32%
Feb 24	-11.6%
Feb 24	-10.32%
Feb 24	-10.49%
Jan 24	-10.56%
Jan 24	-9.92%
Jan 24	-10.37%
Jan 24	-9.11%
Dec 23	-7.87%
Dec 23	-9.4%
Dec 23	-8.19%
Dec 23	-5.33%
Dec 23	-5.02%
Nov 23	-5.04%
Nov 23	-4.96%
Nov 23	-4.67%
Nov 23	-4.32%
Oct 23	-4.67%
Oct 23	-5.69%
Oct 23	-6.79%
Oct 23	-7.82%
Sep 23	-8.89%
Sep 23	-5.76%
Sep 23	-5.16%
Sep 23	-4.2%
Sep 23	-3.7%
Aug 23	-2.04%
Aug 23	-2.02%
Aug 23	-2.01%
Aug 23	-1.96%
Jul 23	-2.16%
Jul 23	-2.37%
Jul 23	-2.88%
Jul 23	-14.01%
Jun 23	-10.32%
Jun 23	-17.23%
Jun 23	-14.51%
Jun 23	-14.14%
Jun 23	-13.13%
May 23	-13.45%
May 23	-13.45%
May 23	-13.45%
May 23	-12.25%
Apr 23	-14.14%
Apr 23	-12.82%
Apr 23	-13.13%
Apr 23	-15.32%
Mar 23	-16.22%
Mar 23	-16.76%
Mar 23	-18.12%
Mar 23	-19.16%
Mar 23	-19.16%
Feb 23	-17.19%
Feb 23	-15.59%
Feb 23	-14.9%
Feb 23	-15.24%

Price to Book

NYMXF Price to Book by quarter
Period	Price to Book
Mar 23	26.8
Mar 23	24.79
Mar 23	23.45
Mar 23	23.45
Feb 23	26.13
Feb 23	28.81
Feb 23	30.15
Feb 23	29.48
Jan 23	27.47
Jan 23	32.83
Jan 23	28.81
Jan 23	27.47
Dec 22	21.44
Dec 22	10.58
Dec 22	12.18
Dec 22	19.23
Dec 22	9.3
Nov 22	10.26
Nov 22	10.26
Nov 22	10.9
Nov 22	10.58
Oct 22	11.54
Oct 22	11.86
Oct 22	10.58
Oct 22	11.22
Sep 22	13.14
Sep 22	28.96
Sep 22	32.09
Sep 22	29.75
Sep 22	28.18
Aug 22	35.22
Aug 22	36.79
Aug 22	45.4
Aug 22	30.53
Jul 22	28.96
Jul 22	26.61
Jul 22	23.48
Jul 22	32.09
Jul 22	32.09
Jun 22	463.8
Jun 22	453.5
Jun 22	546.26
Jun 22	391.66
May 22	432.88
May 22	1298.65
May 22	1329.57
May 22	1453.25
Apr 22	1216.19
Apr 22	1442.94
Apr 22	1442.94
Apr 22	1288.34
Apr 22	1257.42
Mar 22	46.66
Mar 22	52.06
Mar 22	74.42
Mar 22	77.12
Feb 22	60.54
Feb 22	53.21
Feb 22	54.75
Feb 22	63.62
Jan 22	54.37
Jan 22	55.91
Jan 22	61.7
Jan 22	54.75
Dec 21	50.13

No video analysis for this stock yet. Request one from our team.

AI Analysis

Nymox Pharmaceutical Corporation

Video analysis: NYMXF

Similar companies